Get started
TRANSMEDICS GROUP INCTRANSMEDICS GROUP INCTRANSMEDICS GROUP INC

TRANSMEDICS GROUP INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Bonds

1TMDX chart


Full chart

1TMDX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.84 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
94.55
Basic EPS (TTM)
1.35 EUR
Net income (FY)
‪34.26 M‬ EUR
Revenue (FY)
‪426.52 M‬ EUR
Shares float
‪32.59 M‬
Beta (1Y)
0.93

Employees


Employees (FY)
728
Change (1Y)
+144 +24.66%
Revenue / Employee (1Y)
‪585.88 K‬ EUR
Net income / Employee (1Y)
‪47.06 K‬ EUR

About TransMedics Group, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Waleed H. Hassanein
Website
transmedics.com
Headquarters
Andover
Founded
1998
FIGI
BBG01TNWMD97
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1TMDX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1TMDX highest yielding bonds


TMDX5812024
TransMedics Group, Inc. 1.5% 01-JUN-2028
Yield to maturity
−11.10%
Maturity date
Jun 1, 2028

See all 1TMDX bonds 


Check out other big names from the same industry as 1TMDX.

Frequently Asked Questions


The current price of 1TMDX is 114.00 EUR — it has increased by 0.40% in the past 24 hours. Watch TRANSMEDICS GROUP INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange TRANSMEDICS GROUP INC stocks are traded under the ticker 1TMDX.
1TMDX stock has risen by 3.73% compared to the previous week, the month change is a 37.45% rise, over the last year TRANSMEDICS GROUP INC has showed a 37.45% increase.
We've gathered analysts' opinions on TRANSMEDICS GROUP INC future price: according to them, 1TMDX price has a max estimate of 128.89 EUR and a min estimate of 90.93 EUR. Watch 1TMDX chart and read a more detailed TRANSMEDICS GROUP INC stock forecast: see what analysts think of TRANSMEDICS GROUP INC and suggest that you do with its stocks.
1TMDX reached its all-time high on May 21, 2025 with the price of 110.00 EUR, and its all-time low was 78.75 EUR and was reached on Apr 29, 2025. View more price dynamics on 1TMDX chart.
See other stocks reaching their highest and lowest prices.
1TMDX stock is 0.39% volatile and has beta coefficient of 0.93. Track TRANSMEDICS GROUP INC stock price on the chart and check out the list of the most volatile stocks — is TRANSMEDICS GROUP INC there?
Today TRANSMEDICS GROUP INC has the market capitalization of ‪3.85 B‬, it has increased by 5.93% over the last week.
Yes, you can track TRANSMEDICS GROUP INC financials in yearly and quarterly reports right on TradingView.
TRANSMEDICS GROUP INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
1TMDX earnings for the last quarter are 0.65 EUR per share, whereas the estimation was 0.24 EUR resulting in a 165.21% surprise. The estimated earnings for the next quarter are 0.39 EUR per share. See more details about TRANSMEDICS GROUP INC earnings.
TRANSMEDICS GROUP INC revenue for the last quarter amounts to ‪132.68 M‬ EUR, despite the estimated figure of ‪114.32 M‬ EUR. In the next quarter, revenue is expected to reach ‪129.94 M‬ EUR.
1TMDX net income for the last quarter is ‪23.74 M‬ EUR, while the quarter before that showed ‪6.62 M‬ EUR of net income which accounts for 258.39% change. Track more TRANSMEDICS GROUP INC financial stats to get the full picture.
No, 1TMDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 728 employees. See our rating of the largest employees — is TRANSMEDICS GROUP INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRANSMEDICS GROUP INC EBITDA is ‪68.50 M‬ EUR, and current EBITDA margin is 12.97%. See more stats in TRANSMEDICS GROUP INC financial statements.
Like other stocks, 1TMDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRANSMEDICS GROUP INC stock right from TradingView charts — choose your broker and connect to your account.